Balveen Kaur

Augusta University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

61h-index11.7kcitations524works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(268), Cancer Research and Treatments(110), Herpesvirus Infections and Treatments(106), RNA Interference and Gene Delivery(58), CAR-T cell therapy research(53)

Publications517 total

Oncolytic HSV-1-Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis
Cancer Research·2025
ANGI-04. HOST INTERFERON SIGNALING MODULATES EPITHELIAL-TO-MESENCHYMAL TRANSITION IN GLIOBLASTOMA INVASION THROUGH BRAIN CD73
Neuro-Oncology·2025Open Access
DDDR-02. PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide
Neuro-Oncology·2025Open Access
Cancer interrupted: A story of oncolytic HSV-induced killing
Molecular Therapy·2025Open Access
Oncolytic HSV and cancer drug interactions: Current clinical status and future directions
Molecular Therapy·2025· 6 citedOpen Access
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity
Nature Communications·2025· 10 citedOpen Access
β-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapy
Journal for ImmunoTherapy of Cancer·2025· 3 citedOpen Access
Engineering a novel HSV-1 strain for oncolytic therapy of solid tumors
Molecular Therapy Oncology·2025· 1 citedOpen Access
PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide
2025· 1 citedOpen Access
Brain CD73 modulates interferon signaling to regulate glioblastoma invasion
Neuro-Oncology Advances·2025· 2 citedOpen Access
TMET-30. ONCOLYTIC HSV REWIRES METABOLISM TO PROMOTE ANTITUMOR IMMUNITY THROUGH REDUCTIVE CARBOXYLATION AND FERROPTOSIS
Neuro-Oncology·2024Open Access
DDEL-14. NOVEL BLOOD BRAIN BARRIER PENETRATING BI-SPECIFIC ANTIBODY THERAPY FOR BREAST CANCER BRAIN METASTASIS
Neuro-Oncology·2024Open Access
TMIC-58. LEVERAGING VIRO-IMMUNOTHERAPY BY TARGETING IGF2-IGF1R SIGNALING
Neuro-Oncology·2024Open Access
771 Mitigating feedback immunosuppression through IDO inhibition during oncolytic virotherapy of glioblastoma
Regular and Young Investigator Award Abstracts·2024Open Access
TMIC-54. OHSV-MEDIATED NOTCH BLOCKADE FOR BRAIN TUMORS
Neuro-Oncology·2024Open Access
TMIC-61. DEVELOPMENT OF A NOVEL NOTCH-TARGETING ONCOLYTIC HSV FOR GBM TUMORS
Neuro-Oncology·2024Open Access
EXTH-69. DEVELOPMENT OF A NOVEL, HUMAN ANTIBODY TO IMPROVE ONCOLYTIC VIRUS THERAPY FOR GLIOBLASTOMA
Neuro-Oncology·2024Open Access
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy
Neuro-Oncology·2024· 15 citedOpen Access
Exogenous non-coding dsDNA-dependent trans-activation of phagocytes augments anti-tumor immunity
Cell Reports Medicine·2024· 5 citedOpen Access
Abstract LB262: Reprogramming the tumor microenvironment by targeting IGF2-IGF1R signaling, enhancing viro-immunotherapy
Cancer Research·2024
page 1 of 26Next →

Frequent Co-authors

E. Antonio Chiocca(16), Jianhua Yu(12), Ji Young Yoo(12), Michael A. Caligiuri(11), Erwin G. Van Meir(10), Daniel J. Brat(8), Jayson Hardcastle(6), Ralph Weissleder(5), Jianying Zhang(5), Arnab Chakravarti(5), Giulia Fulci(4), Jianfeng Han(4), Walter H. Meisen(4), Joseph C. Glorioso(4), Brian Hurwitz(4), Jeffrey Wojton(4), Sean Lawler(4), Michal O. Nowicki(4), Kazuhiko Kurozumi(4), Tae Jin Lee(4)